GlassScriptPhysician profile
William Stafford
NPI 1376214908
$5,190.82
in general payments reported to CMS, 2019-2025
24 companies · $878 in 2025
The $878 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $1,038 · 2023: $2,286 · 2024: $698 · 2025: $878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,669 · Travel and Lodging: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.84 |
| Travel and Lodging | $1,193.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $1,818.47 | 2023-2024 | Accucinch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,287.20 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $193.11 | 2022-2024 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $177.25 | 2021-2022 | |
| Heartflow, INC. | $162.21 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $153.66 | 2022-2025 | |
| Abbott Laboratories | $145.99 | 2025 | 2nd Gen Centrimag Primary Console |
| Inari Medical, INC. | $140.00 | 2022 | |
| Philips North America LLC | $136.17 | 2022-2024 | (Ck4) Mcot |
| Boston Scientific Corporation | $132.17 | 2024-2025 | Watchman Flx, General - Structural Heart, Watchman Access System |
| Janssen Pharmaceuticals, INC | $128.60 | 2021-2022 | |
| Angiodynamics, INC. | $119.46 | 2024 | Alphavac |
| Abiomed | $101.98 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $94.53 | 2022-2023 | Farxiga |
| Cvrx, INC. | $86.26 | 2023-2025 | Barostim Neo System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.72 | 2022-2023 | Jardiance |
| Daiichi Sankyo INC. | $59.52 | 2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $51.53 | 2022-2023 | |
| Preventice Services, LLC | $47.75 | 2021 | |
| Ge Healthcare | $29.86 | 2022 | |
| Amarin Pharma, INC. | $20.71 | 2022 | |
| Pfizer INC. | $18.54 | 2024 | |
| Sanofi-Aventis U.S. LLC | $13.82 | 2022 | |
| Amgen INC. | $11.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stafford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.